Categories: Technology

NEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)

Nanterre, June 1, 2026

Declaration of transactions on treasury shares
(period from May 25 to 29, 2026)

As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between May 25 and 29, 2026 (ISIN code FR0004050250):

Day Total daily volume
(in number of shares)
Weighted average price
(unit daily)
05/25/2026
05/26/2026 3,331 €38.14
05/27/2026 12,925 €38.04
05/28/2026
05/29/2026
Total 16,256  

As of May 29, 2026, excluding the liquidity contract, NEURONES now holds 462,002 of the 24,328,716 shares comprising the company’s capital (i.e., 1.90%).

All press releases relating to the share buyback program are published in the “Regulated Information” section (under “Weekly declarations of the share buyback transactions” and “Share buyback programs”) of the company’s website.

About NEURONES

With 7,400 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations with their digital projects, IT infrastructures transformation and AI adoption.

Euronext Paris (compartment A – NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible
www.neurones.net

GlobeNews Wire

Recent Posts

AARAV Fragrances & Flavors Strengthens Leadership Team with Appointment of Yatin Sheth as COO – Ingredient Business

MUMBAI, India, June 22, 2026 /PRNewswire/ -- AARAV Fragrances & Flavors Pvt. Ltd., one of…

41 minutes ago

Moldova Digital Summit 2026: EU Commissioner Marta Kos Praises Moldova as a Digital Success Story

CHISINAU, Moldova, June 22, 2026 /PRNewswire/ -- Moldova Digital Summit 2026 (MDS26) brought approximately 4,000…

2 hours ago

The Search For India’s Next Breakthrough Innovations Begins As Marico Innovation Foundation Invites Applications For Indian Innovation Icons 2027

The biennial platform continues its legacy of championing scalable solutions creating socio-economic and environmental changeThe…

2 hours ago

UN GLOBAL COMPACT LAUNCHES FIRST PRACTICAL GUIDE FOR COMPANIES LEADING ON BLENDED FINANCE

New Playbook empowers businesses to take an active role in structuring deals within the $24B…

2 hours ago

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe…

12 hours ago

Boston Dental Named The Best Dentist in Boston

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services June 19,…

12 hours ago